MCID: GLS001
MIFTS: 52

Gliosarcoma malady

Rare diseases, Neuronal diseases, Cancer diseases categories

Aliases & Classifications for Gliosarcoma

About this section
Sources:
8Disease Ontology, 42NIH Rare Diseases, 10DISEASES, 44Novoseek, 48Orphanet, 61UMLS, 39NCIt, 33MeSH, 56SNOMED-CT, 62UMLS via Orphanet
See all sources

Aliases & Descriptions for Gliosarcoma:

Name: Gliosarcoma 8 42 10 44 48 61
Glioblastoma with Sarcomatous Component 8
 
Sarcomatous Glioblastoma 42


Classifications:



Characteristics (Orphanet epidemiological data):

48
gliosarcoma:
Inheritance: Not applicable; Age of onset: Adult


External Ids:

Disease Ontology8 DOID:3071
NCIt39 C3796
MeSH33 D018316
Orphanet48 251576
UMLS via Orphanet62 C0206726

Summaries for Gliosarcoma

About this section
Wikipedia:64 Gliosarcoma is a rare type of glioma, a cancer of the brain that comes from glial, or supportive, brain... more...

MalaCards based summary: Gliosarcoma, also known as glioblastoma with sarcomatous component, is related to sarcoma and anaplastic ependymoma. An important gene associated with Gliosarcoma is FGFR3 (fibroblast growth factor receptor 3), and among its related pathways are Angiogenesis and NF-KappaB Family Pathway. The compounds bcnu and suberoylanilide hydroxamic acid have been mentioned in the context of this disorder. Affiliated tissues include brain, spinal cord and bone, and related mouse phenotypes are hearing/vestibular/ear and pigmentation.

Related Diseases for Gliosarcoma

About this section

Diseases related to Gliosarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 120)
idRelated DiseaseScoreTop Affiliating Genes
1sarcoma30.8TKT, CDK4, PDGFRB, TP53
2anaplastic ependymoma30.7PTEN, GFAP
3ependymoma30.6EGFR, GFAP, MGMT
4medulloblastoma30.5CDK4, TP53, GFAP, MGMT
5giant cell glioblastoma30.5GFAP, PTEN, EGFR
6rhabdomyosarcoma30.4CDK4, GJA1, PDGFRB, TP53
7glioblastoma multiforme30.4MGMT, GFAP, EGFR, CDK4, GJA1, PDGFRB
8oligodendroglioma30.3MGMT, GFAP, PTEN, EGFR
9pilocytic astrocytoma30.1IDH1, GFAP, PTEN, PDGFRB, CDK4, MGMT
10grade iii astrocytoma30.1CDK4, PDGFRB, TP53, PTEN, GFAP, MGMT
11pancreatic cancer29.8EGFR, NFKBIA, PDGFRB, MGMT
12chondrosarcoma29.7PDGFRB, NFKBIA, CDK4, FGFR1, FGFR3
13glioblastoma29.3IDH1, GFAP, PTEN, TP53, PDGFRB, GJA1
14astrocytoma29.2GJA1, NFKBIA, CDK4, EGFR, FGFR1, PDGFRB
15melanoma28.7SNAI2, TP53, PTEN, TFRC, MGMT, PDGFRB
16cerebritis10.5
17gliomatosis cerebri10.5PTEN, GFAP
18gemistocytic astrocytoma10.5PTEN, GFAP
19osteoglophonic dysplasia10.5FGFR1
20mismatch repair cancer syndrome10.5PTEN
21pineoblastoma10.5GFAP
22oligoastrocytoma10.5GFAP, MGMT
23thanatophoric dysplasia, type i10.4FGFR3
24subependymal giant cell astrocytoma10.4GFAP
25meningioma, familial10.4GFAP, PTEN, PDGFRB
26tuberous sclerosis10.4GFAP, PTEN, PDGFRB
27nelson syndrome10.4PPARG
28mesothelioma10.4PDGFRB, CDK4, TKT
29osteochondroma10.4FGFR3
30mesothelioma, somatic10.4CDK4, PDGFRB, SNAI2
31fgfr-related craniosynostosis syndromes10.4FGFR1, FGFR3
32jackson-weiss syndrome10.4FGFR1, FGFR3
33systemic mastocytosis10.4PDGFRB, FGFR1
34leiomyosarcoma10.4CDK4, PDGFRB, TP53
35muenke syndrome10.4FGFR3, FGFR1
36li-fraumeni syndrome10.3PTEN, TP53
37esophageal cancer10.3TP53, PDGFRB, CDK4
38pfeiffer syndrome10.3FGFR1, FGFR3
39choroid plexus papilloma10.3GFAP, TP53
40crouzon syndrome10.3FGFR1, FGFR3
41apert syndrome10.3FGFR1, FGFR3
42hypochondroplasia10.3FGFR1, FGFR3
43achondroplasia10.3FGFR3
44skin benign neoplasm10.3FGFR3, GJA1, MGMT
45acrocephalosyndactylia10.3FGFR1, FGFR3
46brain cancer10.3MGMT, GJA1, EGFR
47bone marrow cancer10.3FGFR1, TKT, PDGFRB
48adult brainstem gliosarcoma10.3
49saethre-chotzen syndrome10.3FGFR1, FGFR3
50papilloma10.3TP53, GJA1, FGFR3

Graphical network of the top 20 diseases related to Gliosarcoma:



Diseases related to gliosarcoma

Symptoms for Gliosarcoma

About this section

Drugs & Therapeutics for Gliosarcoma

About this section

Drug clinical trials:

Search ClinicalTrials for Gliosarcoma

Search NIH Clinical Center for Gliosarcoma

Genetic Tests for Gliosarcoma

About this section

Anatomical Context for Gliosarcoma

About this section

MalaCards organs/tissues related to Gliosarcoma:

31
Brain, Spinal cord, Bone, Smooth muscle, Lung, Nk cells, T cells, Thalamus, Pineal

Animal Models for Gliosarcoma or affiliated genes

About this section

MGI Mouse Phenotypes related to Gliosarcoma:

35 (show all 27)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053779.1FGFR1, EGFR, GJA1, PPARG, FGFR3
2MP:00011869.1EGFR, SNAI2, TP53, PTEN
3MP:00053759.0EGFR, TP53, PDGFRB, PTEN, PPARG
4MP:00053718.8GJA1, PTEN, TP53, TACC3, EGFR, FGFR1
5MP:00030128.8TP53, FGFR3, FGFR1, PPARG, EGFR, GJA1
6MP:00020068.6PTEN, PPARG, MGMT, TP53, TACC3, CDK4
7MP:00053678.3EGFR, FGFR3, CDK4, PDGFRB, TP53, PTEN
8MP:00053708.1TP53, EGFR, PPARG, TKT, PTEN, TACC3
9MP:00053698.1EGFR, PTEN, TP53, PDGFRB, GFAP, PPARG
10MP:00028738.1NFKBIA, PPARG, EGFR, TACC3, GJA1, PDGFRB
11MP:00053828.1GJA1, TACC3, LZTR1, EGFR, FGFR1, FGFR3
12MP:00053907.9PPARG, FGFR3, PTEN, TP53, SNAI2, FGFR1
13MP:00053817.7TFRC, GFAP, PTEN, SNAI2, PDGFRB, CDK4
14MP:00053897.5SNAI2, TP53, PTEN, PPARG, PDGFRB, GJA1
15MP:00053807.4PPARG, TFRC, FGFR1, SNAI2, TACC3, CDK4
16MP:00053857.4TFRC, GFAP, PTEN, TP53, PDGFRB, CDK4
17MP:00053797.4PDGFRB, MGMT, PTEN, TP53, SNAI2, GJA1
18MP:00053867.3FGFR3, FGFR1, TKT, TP53, PTEN, SNAI2
19MP:00107717.2FGFR3, TFRC, PTEN, TP53, SNAI2, PDGFRB
20MP:00053847.2CDK4, PDGFRB, PPARG, TFRC, GFAP, PTEN
21MP:00053917.2SNAI2, PDGFRB, TP53, TKT, PTEN, PPARG
22MP:00053977.0TP53, PTEN, IDH1, GJA1, TFRC, SNAI2
23MP:00053767.0LZTR1, NFKBIA, PDGFRB, TP53, PTEN, GFAP
24MP:00036316.7PPARG, TFRC, TP53, SNAI2, FGFR3, FGFR1
25MP:00053876.5TACC3, FGFR3, FGFR1, EGFR, TP53, PPARG
26MP:00053786.3PPARG, TACC3, TFRC, CDK4, EGFR, TKT
27MP:00107685.9TFRC, SNAI2, PDGFRB, NFKBIA, TACC3, LZTR1

Publications for Gliosarcoma

About this section

Articles related to Gliosarcoma:

(show top 50)    (show all 311)
idTitleAuthorsYear
1
Cell-density-dependent manifestation of partial characteristics for neuronal precursors in a newly established human gliosarcoma cell line. (25539862)
2015
2
A Nonradiated Grade II Glioma That Underwent Delayed Malignant Transformation to a Gliosarcoma with Meningeal Growth and Dissemination. (24971682)
2014
3
Temozolomide use in adult patients with gliosarcoma: an evolving clinical practice. (23266723)
2013
4
Gliosarcoma with osseous tissue: an occasional metaplastic component. (22476731)
2013
5
Intracerebral administration of heat-inactivated Staphylococcus epidermidis enhances oncolysis and prolongs survival in a 9L orthotopic gliosarcoma model. (23652608)
2013
6
De novo gliosarcoma occurring in the posterior fossa of a 11-year-old girl. (22939178)
2012
7
Campylobacteremia in stage IV gliosarcoma with bevacizumab treatment. (23882353)
2012
8
Intracranial MEMS based temozolomide delivery in a 9L rat gliosarcoma model. (22591609)
2012
9
Gliosarcoma with prominent smooth muscle component (gliomyosarcoma): a report of 10 cases. (21393877)
2011
10
Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma. (21896554)
2011
11
Gliosarcoma: a study of four cases. (21139839)
2010
12
Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity. (19618114)
2010
13
An unusual case of intraventricular gliosarcoma. (19788054)
2009
14
Enhancement of survival of 9L gliosarcoma bearing rats following intracerebral delivery of drugs in combination with microbeam radiation therapy. (18635331)
2008
15
Irradiation of intracerebral 9L gliosarcoma by a single array of microplanar x-ray beams from a synchrotron: balance between curing and sparing. (18263945)
2008
16
Inhibitors of EGFR signaling retard cytotoxicity of fenretinide in rat gliosarcoma cells. (17577665)
2008
17
Gliosarcoma: an audit from a single institution in India of 24 post-irradiated cases over 15 years. (19052388)
2008
18
Giant infantile gliosarcoma: magnetic resonance imaging findings. (18403585)
2008
19
Gliosarcoma with primitive neuroectodermal differentiation: case report and review of the literature. (17406789)
2007
20
Gliosarcoma cell death after radiosurgery in a rat model. (16015490)
2005
21
Bioluminescence imaging of the response of rat gliosarcoma to ALA-PpIX-mediated photodynamic therapy. (15362932)
2004
22
Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps. (14565159)
2003
23
Gliosarcoma with areas of primitive neuroepithelial differentiation and extracranial metastasis. (12143929)
2002
24
Primary C1-2, intradural, extramedullary meningeal sarcoma with glial fibrillary acidic protein-immunoreactive components: a spinal gliosarcoma? Case report and review of the literature. (12450287)
2002
25
Effects of IFN-gamma and interleukin-1beta on major histocompatibility complex antigen and intercellular adhesion molecule-1 expression by 9L gliosarcoma: relevance to its cytolysis by alloreactive cytotoxic T lymphocytes. (12581494)
2002
26
In vivo L-DOPA production by genetically modified primary rat fibroblast or 9L gliosarcoma cell grafts via coexpression of GTPcyclohydrolase I with tyrosine hydroxylase. (9628761)
1998
27
A clinico-pathological study of 29 cases of gliosarcoma with special reference to two unique variants. (9378529)
1997
28
Induction of acquired immunity in rats that have eliminated intracranial gliosarcoma cells by the expression of herpes simplex virus-thymidine kinase gene and ganciclovir administration. (9216859)
1997
29
Postirradiated and nonirradiated gliosarcoma: immunophenotypical profile. (8951202)
1996
30
Regional differences in apoptosis in murine gliosarcoma (T9) induced by mild hyperthermia. (9044904)
1996
31
Curative potential of herpes simplex virus thymidine kinase gene transfer in rats with 9L gliosarcoma. (8845388)
1996
32
A rat glioma model, CNS-1, with invasive characteristics similar to those of human gliomas: a comparison to 9L gliosarcoma. (7760095)
1994
33
Unusual evolution and computerized tomographic appearance of a gliosarcoma. (8087741)
1994
34
Hyperthermic enhancement of high dose-rate irradiation in 9L gliosarcoma cells. (8270439)
1994
35
Synergistic effect between intraneoplastic methotrexate and radiation on experimental intracerebral rat gliosarcoma. (8008164)
1994
36
The efficacy and distribution of suramin in the treatment of the 9L gliosarcoma. (8177391)
1994
37
Oxygenation of the rat 9L gliosarcoma and the rat 13672 mammary carcinoma with various doses of a hemoglobin solution. (7994406)
1994
38
Suppression of 9L gliosarcoma growth by copper depletion with copper-deficient diet and D-penicillamine. (8145063)
1993
39
Relationship of perfusion to edema in the 9L gliosarcoma. (8410147)
1993
40
Establishment of a new cell line derived from a human gliosarcoma. (1545891)
1992
41
Decreased susceptibility of lined human gliosarcoma cells to lymphokine-activated killer cell cytolysis by gamma-interferon treatment. (2137025)
1990
42
Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L rat gliosarcoma: allogeneic cytotoxic T lymphocytes prevent tumor take. (2263613)
1990
43
Thorotrast-associated gliosarcoma. Including comments on thorotrast use and review of sequelae with particular reference to lesions of the central nervous system. (3289727)
1988
44
Growth of 9-L and RT-9 gliosarcoma in female rats. (3598624)
1987
45
Establishment and characterization of a cell line from a human gliosarcoma. (3019542)
1986
46
Effect of microsurgical and carbon dioxide and argon laser resection on recurrence of the intracerebral 9L rat gliosarcoma. (6420723)
1984
47
Immunogenetic and immunologic aspects of gliosarcoma growth in rats. (6604839)
1983
48
Experimental brain tumor chemotherapy: DNA damage in the rat gliosarcoma 9L treated with CCNU. (583703)
1977
49
Association of a phaeochromocytoma and cerebral gliosarcoma with neurofibromatosis. (4289271)
1967
50
Gliosarcoma in a Full-time Stillborn Foetus. (19985093)
1926

Variations for Gliosarcoma

About this section

Cosmic variations for Gliosarcoma:

6
id Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Conf
1564NRAScentral nervous system,brain,glioma,gliosarcoma1

Expression for genes affiliated with Gliosarcoma

About this section
Search GEO for disease gene expression data for Gliosarcoma.

Pathways for genes affiliated with Gliosarcoma

About this section

Pathways related to Gliosarcoma according to GeneCards Suite gene sharing:

(show top 50)    (show all 69)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.8PDGFRB, FGFR1, FGFR3
2
Show member pathways
9.7NFKBIA, EGFR, FGFR1, FGFR3
3
Show member pathways
9.7FGFR1, FGFR3, PTEN
49.7TP53, NFKBIA, CDK4
5
Show member pathways
9.6FGFR3, FGFR1, EGFR, PDGFRB
69.6FGFR3, FGFR1, EGFR, PDGFRB
79.6PDGFRB, EGFR, FGFR1, FGFR3
8
Show member pathways
9.6FGFR3, FGFR1, EGFR, PDGFRB
99.6FGFR1, EGFR, SNAI2
109.6TACC3, TP53, TACC1, NFKBIA
11
Show member pathways
9.5TACC3, MGMT, TP53, CDK4
12
Show member pathways
9.5NFKBIA, TP53, EGFR, CDK4
13
Show member pathways
9.5PDGFRB, EGFR, TP53, NFKBIA
14
Show member pathways
MAPK signaling pathway36
9.4EGFR, FGFR3, PDGFRB, FGFR1, TP53
15
Show member pathways
9.4EGFR, FGFR1, PDGFRB, FGFR3, NFKBIA
16
Show member pathways
9.3PDGFRB, PPARG, FGFR3, FGFR1, EGFR
179.3FGFR1, SNAI2, FGFR3, GFAP
189.3CDK4, NFKBIA, PDGFRB, TP53
199.3EGFR, CDK4, TP53, PTEN
20
Show member pathways
Toll-like receptor signaling pathway36
Regulation of toll-like receptor signaling pathway36
9.2TP53, NFKBIA, PTEN, CDK4
219.2PTEN, TP53, CDK4, NFKBIA
22
Show member pathways
9.2EGFR, PDGFRB, PTEN, FGFR3, FGFR1
239.1TP53, GFAP, GJA1, CDK4, EGFR
249.1PPARG, PTEN, TKT, IDH1
25
Show member pathways
9.1FGFR1, FGFR3, NFKBIA, EGFR, TP53, PDGFRB
26
Show member pathways
9.1PDGFRB, TP53, EGFR, FGFR1, FGFR3, NFKBIA
27
Show member pathways
9.1FGFR3, NFKBIA, FGFR1, EGFR, PDGFRB, TP53
289.1PDGFRB, FGFR3, PTEN, TP53, EGFR
299.1EGFR, PTEN, TP53, SNAI2
30
Show member pathways
9.0EGFR, FGFR3, FGFR1, PTEN, TP53, NFKBIA
31
Show member pathways
Development EGFR signaling via PIP359
Development PDGF signaling via MAPK cascades59
Apoptosis and survival Anti apoptotic action of membrane bound ESR159
Signaling of Hepatocyte Growth Factor Receptor36
Development EGFR signaling via small GTPases59
Development Neurotrophin family signaling59
Apoptosis and survival NGF signaling pathway59
Apoptosis and survival Role of CDK5 in neuronal death and survival59
9.0PTEN, NFKBIA, PDGFRB, TP53, EGFR
32
Show member pathways
8.9FGFR1, EGFR, PDGFRB, TP53, PTEN, FGFR3
33
Show member pathways
8.9EGFR, PTEN, FGFR1, TP53, FGFR3, PDGFRB
34
Show member pathways
8.9PTEN, NFKBIA, PDGFRB, EGFR, FGFR1, FGFR3
35
Show member pathways
8.9PTEN, PDGFRB, NFKBIA, FGFR3, FGFR1, EGFR
36
Show member pathways
8.9EGFR, PDGFRB, PTEN, NFKBIA, FGFR1, FGFR3
37
Show member pathways
8.9FGFR3, PTEN, FGFR1, EGFR, NFKBIA, PDGFRB
388.9NFKBIA, FGFR1, EGFR, CDK4, TP53, PTEN
39
Show member pathways
8.8CDK4, FGFR3, FGFR1, EGFR, NFKBIA, PDGFRB
408.7CDK4, PDGFRB, TP53, MGMT, PTEN, EGFR
41
Show member pathways
8.6FGFR3, FGFR1, PDGFRB, NFKBIA, PTEN, EGFR
428.6FGFR3, FGFR1, CDK4, EGFR, PDGFRB, TP53
438.6FGFR3, EGFR, CDK4, FGFR1, PTEN, TP53
44
Show member pathways
8.4FGFR1, EGFR, PTEN, PPARG, NFKBIA, PDGFRB
45
Show member pathways
8.4FGFR1, EGFR, NFKBIA, PDGFRB, SNAI2, PTEN
46
Show member pathways
8.4FGFR3, FGFR1, EGFR, TP53, NFKBIA, PDGFRB
47
Show member pathways
Signaling Pathways in Glioblastoma36
8.3CDK4, EGFR, FGFR3, FGFR1, NFKBIA, PDGFRB
488.1PPARG, PTEN, TP53, PDGFRB, FGFR3, FGFR1
49
Show member pathways
7.5PDGFRB, FGFR3, EGFR, FGFR1, CDK4, SNAI2

Compounds for genes affiliated with Gliosarcoma

About this section

Compounds related to Gliosarcoma according to GeneCards Suite gene sharing:

(show top 50)    (show all 170)
idCompoundScoreTop Affiliating Genes
1bcnu449.8MGMT, GFAP, EGFR, TP53
2suberoylanilide hydroxamic acid449.7TP53, PPARG, NFKBIA, EGFR, FGFR1
3bortezomib44 50 1111.5NFKBIA, FGFR3, EGFR, TP53, PTEN
4topotecan44 1110.5MGMT, EGFR, PDGFRB, TKT, TP53
5curcumin449.3EGFR, CDK4, NFKBIA, MGMT, PPARG, TP53
6egcg449.3EGFR, CDK4, NFKBIA, PDGFRB, TP53, MGMT
7gemcitabine44 50 1111.3PDGFRB, NFKBIA, TP53, PTEN, EGFR
8thymidylate449.2TKT, EGFR, CDK4, TP53, MGMT, NFKBIA
9retinoid449.2EGFR, CDK4, NFKBIA, PPARG, TP53, GJA1
10cetuximab44 50 1111.2PTEN, PDGFRB, TKT, EGFR
11sb 20358044 6010.1CDK4, TP53, FGFR1, PPARG, GJA1, NFKBIA
12imatinib44 50 1111.1FGFR3, FGFR1, EGFR, PDGFRB, PTEN, TKT
13gefitinib44 50 1111.1TKT, PTEN, EGFR, PDGFRB, CDK4
14n acetylcysteine449.0TFRC, NFKBIA, CDK4, EGFR, TP53, PPARG
1512-o-tetradecanoylphorbol 13-acetate448.9CDK4, MGMT, FGFR1, TKT, GJA1, NFKBIA
16gf 109203x44 609.9TKT, PPARG, TFRC, NFKBIA, EGFR
17pd 98,059448.9PTEN, FGFR1, GFAP, GJA1, NFKBIA, CDK4
18etoposide44 50 60 1111.8TKT, GJA1, NFKBIA, TP53, PTEN, MGMT
19bromodeoxyuridine448.8FGFR1, GJA1, NFKBIA, PDGFRB, GFAP, TKT
20calcitriol44 60 24 1111.8CDK4, NFKBIA, PDGFRB, GJA1, PTEN, TFRC
21methionine448.7PDGFRB, GFAP, MGMT, PTEN, FGFR1, GJA1
22oligonucleotide448.6PDGFRB, TP53, FGFR3, FGFR1, CDK4, NFKBIA
23dexamethasone44 50 28 1111.6NFKBIA, TFRC, MGMT, PPARG, GFAP, FGFR3
24phosphotyrosine448.5EGFR, FGFR3, PTEN, FGFR1, TKT, CDK4
25thymidine44 249.5FGFR1, TKT, CDK4, GJA1, TFRC, GFAP
26glutamate448.5GJA1, FGFR3, TKT, TFRC, IDH1, GFAP
275fluorouracil448.5EGFR, PTEN, TP53, MGMT, NFKBIA, CDK4
28agar448.4PTEN, CDK4, EGFR, PDGFRB, GFAP, GJA1
29doxorubicin44 50 1110.4NFKBIA, MGMT, FGFR3, TFRC, CDK4, GJA1
30phosphatidylinositol448.4TFRC, EGFR, FGFR1, NFKBIA, CDK4, GJA1
31h2o2448.3GJA1, PDGFRB, TP53, PTEN, TFRC, NFKBIA
32rapamycin448.3PTEN, EGFR, PDGFRB, NFKBIA, CDK4, TKT
33glucose448.2PTEN, CDK4, FGFR1, GFAP, GJA1, MGMT
34vitamin d448.2NFKBIA, TFRC, PTEN, PPARG, CDK4, PDGFRB
35progesterone44 28 60 24 1112.1NFKBIA, PTEN, MGMT, GFAP, TP53, PDGFRB
36alanine448.0NFKBIA, TFRC, PPARG, PTEN, CDK4, GFAP
37ly294002448.0CDK4, NFKBIA, GJA1, TP53, PTEN, TFRC
38cysteine448.0GFAP, PTEN, PDGFRB, FGFR3, FGFR1, CDK4
39cycloheximide447.8PPARG, TP53, PTEN, GFAP, GJA1, NFKBIA
40paclitaxel44 50 119.8MGMT, TFRC, FGFR1, EGFR, CDK4, PDGFRB
41paraffin447.6TFRC, GFAP, PTEN, TP53, PDGFRB, GJA1
42calcium44 50 24 1110.6GFAP, PTEN, PDGFRB, GJA1, NFKBIA, CDK4
43testosterone44 60 24 1110.5CDK4, TKT, NFKBIA, GJA1, PDGFRB, PTEN
44cisplatin44 50 60 1110.5MGMT, TFRC, PTEN, TP53, PDGFRB, GJA1
45genistein44 28 60 1 24 1112.3GFAP, TFRC, MGMT, FGFR1, EGFR, PTEN
46serine447.2CDK4, GJA1, TFRC, GFAP, PTEN, TP53
47retinoic acid44 248.1FGFR1, EGFR, TKT, CDK4, NFKBIA, GJA1
48tyrosine447.1CDK4, PDGFRB, NFKBIA, TFRC, PTEN, FGFR3
49vegf446.9FGFR3, PPARG, MGMT, FGFR1, EGFR, TKT
50estrogen446.6CDK4, PPARG, NFKBIA, GJA1, PDGFRB, SNAI2

GO Terms for genes affiliated with Gliosarcoma

About this section

Cellular components related to Gliosarcoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cytoplasmic membrane-bounded vesicleGO:00160239.3TFRC, PDGFRB, FGFR1, FGFR3
2cytoplasmGO:00057377.6GFAP, PTEN, TP53, SNAI2, PDGFRB, NFKBIA
3cytosolGO:00058297.5PPARG, IDH1, GFAP, PTEN, TP53, NFKBIA
4nucleusGO:00056346.7FGFR3, PPARG, MGMT, PTEN, TP53, SNAI2

Biological processes related to Gliosarcoma according to GeneCards Suite gene sharing:

(show all 37)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathwayGO:009008010.5FGFR3, FGFR1
2positive regulation of phospholipase activityGO:001051810.5FGFR1, FGFR3
3interkinetic nuclear migrationGO:002202710.4TACC3, TACC1
4MAPK cascadeGO:000016510.3FGFR1, EGFR, FGFR3
5positive regulation of phospholipase C activityGO:001086310.3FGFR1, PDGFRB
6digestive tract morphogenesisGO:004854610.3EGFR, FGFR3
7regulation of microtubule-based processGO:003288610.3TACC1, TACC3
8cytoplasmic sequestering of transcription factorGO:004299410.3NFKBIA, TACC3
9response to fluid shear stressGO:003440510.2GJA1, PDGFRB
10regulation of peptidyl-tyrosine phosphorylationGO:005073010.2PDGFRB, EGFR
11positive regulation of MAP kinase activityGO:004340610.2EGFR, PDGFRB, FGFR1
12negative regulation of macrophage derived foam cell differentiationGO:001074510.2NFKBIA, PPARG
13response to hyperoxiaGO:005509310.1PDGFRB, CDK4
14positive regulation of ERK1 and ERK2 cascadeGO:007037410.1FGFR3, EGFR, PDGFRB
15cell divisionGO:005130110.0CDK4, TACC1, SEPT14
16peptidyl-tyrosine phosphorylationGO:001810810.0FGFR3, PDGFRB, FGFR1, EGFR
17protein autophosphorylationGO:004677710.0EGFR, PDGFRB, FGFR1, FGFR3
18white fat cell differentiationGO:005087210.0SNAI2, PPARG
19regulation of tight junction assemblyGO:0200081010.0GJA1, SNAI2
20response to toxic substanceGO:00096369.9MGMT, PDGFRB, CDK4
21cellular response to ionizing radiationGO:00714799.9MGMT, TP53, SNAI2
22cellular response to epidermal growth factor stimulusGO:00713649.8SNAI2, EGFR
23long-term synaptic potentiationGO:00602919.7GFAP, PTEN
24positive regulation of vasoconstrictionGO:00459079.7EGFR, GJA1
25cell migrationGO:00164779.6PDGFRB, PTEN, FGFR1
26phosphatidylinositol-mediated signalingGO:00480159.6EGFR, FGFR3, PTEN, PDGFRB, FGFR1
27fibroblast growth factor receptor signaling pathwayGO:00085439.6PTEN, PDGFRB, EGFR, FGFR1, FGFR3
28epidermal growth factor receptor signaling pathwayGO:00071739.6FGFR1, PDGFRB, EGFR, PTEN, FGFR3
29positive regulation of cell migrationGO:00303359.5SNAI2, PDGFRB, EGFR
30response to drugGO:00424939.5CDK4, PPARG, PTEN, MGMT
31negative regulation of transcription from RNA polymerase II promoterGO:00001229.4FGFR1, SNAI2, TP53, FGFR3, PPARG
32negative regulation of apoptotic processGO:00430669.4PTEN, TP53, PDGFRB, NFKBIA, EGFR
33heart developmentGO:00075079.4PPARG, PTEN, GJA1
34Fc-epsilon receptor signaling pathwayGO:00380959.3EGFR, NFKBIA, PDGFRB, FGFR3, PTEN, FGFR1
35neurotrophin TRK receptor signaling pathwayGO:00480119.3PTEN, FGFR3, EGFR, NFKBIA, PDGFRB, FGFR1
36positive regulation of cell proliferationGO:00082849.2EGFR, PTEN, PDGFRB, CDK4, FGFR3, FGFR1
37innate immune responseGO:00450879.0FGFR3, EGFR, NFKBIA, FGFR1, PDGFRB, PTEN

Molecular functions related to Gliosarcoma according to GeneCards Suite gene sharing:

(show all 10)
idNameGO IDScoreTop Affiliating Genes
1fibroblast growth factor-activated receptor activityGO:000500710.2FGFR3, FGFR1
2fibroblast growth factor bindingGO:001713410.1FGFR3, FGFR1
3protein tyrosine kinase activityGO:00047139.8FGFR3, FGFR1, EGFR, PDGFRB
4platelet-derived growth factor receptor bindingGO:00051619.6PDGFRB, PTEN
5identical protein bindingGO:00428029.4TFRC, TP53, NFKBIA, EGFR, FGFR1
6protein kinase bindingGO:00199019.3PTEN, TP53, PDGFRB, EGFR
7enzyme bindingGO:00198999.3PPARG, PTEN, TP53, NFKBIA, EGFR
8chromatin bindingGO:00036829.3PPARG, TP53, SNAI2, EGFR
9ATP bindingGO:00055248.7TP53, PDGFRB, CDK4, EGFR, FGFR1, FGFR3
10protein bindingGO:00055157.0FGFR3, PPARG, TFRC, PTEN, TP53, SEPT14

Sources for Gliosarcoma

About this section
2CDC
12ExPASy
13FDA
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
33MeSH
34MESH via Orphanet
35MGI
38NCI
39NCIt
40NDF-RT
43NINDS
44Novoseek
46OMIM
47OMIM via Orphanet
51PubMed
52QIAGEN
57SNOMED-CT via Orphanet
61UMLS
62UMLS via Orphanet